MyFinsight
Home
Blog
About
Contact
Download
Download image
Nuplazid
$680,086K
(11.60%↑ Y/Y)
Daybue
$391,419K
(12.34%↑ Y/Y)
Total revenues
$1,071,505K
(11.87%↑ Y/Y)
Income (loss) from
operations
$104,811K
(-54.59%↓ Y/Y)
Interest income, net
$31,722K
(24.61%↑ Y/Y)
Other income
$2,371K
(30.06%↑ Y/Y)
Total operating
expenses
$966,694K
(32.97%↑ Y/Y)
Income tax (benefit)
expense
-$252,096K
(-897.17%↓ Y/Y)
Income (loss) before
income taxes
$138,904K
(-46.18%↓ Y/Y)
Selling, general and
administrative
$548,894K
(12.38%↑ Y/Y)
Research and development
$328,802K
(8.43%↑ Y/Y)
Cost of product sales
$88,998K
(8.75%↑ Y/Y)
Consolidated net income
$391,000K
(72.66%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)